Digital Health Research Lab, College of Medicine and Public Health, Flinders University, Adelaide, SA, 5042, Australia.
Barossa Hills Fleurieu Local Health Network, SA Health, 29 North St, Tarrawatta (Angaston), Peramangk Country, Adelaide, SA, 5353, Australia.
BMC Med Inform Decis Mak. 2023 Jan 30;23(1):22. doi: 10.1186/s12911-022-02091-2.
Maintaining medication adherence can be challenging for people living with mental ill-health. Clinical decision support systems (CDSS) based on automated detection of problematic patterns in Electronic Health Records (EHRs) have the potential to enable early intervention into non-adherence events ("flags") through suggesting evidence-based courses of action. However, extant literature shows multiple barriers-perceived lack of benefit in following up low-risk cases, veracity of data, human-centric design concerns, etc.-to clinician follow-up in real-world settings. This study examined patterns in clinician decision making behaviour related to follow-up of non-adherence prompts within a community mental health clinic.
The prompts for follow-up, and the recording of clinician responses, were enabled by CDSS software (AI). De-identified clinician notes recorded after reviewing a prompt were analysed using a thematic synthesis approach-starting with descriptions of clinician comments, then sorting into analytical themes related to design and, in parallel, a priori categories describing follow-up behaviours. Hypotheses derived from the literature about the follow-up categories' relationships with client and medication-subtype characteristics were tested.
The majority of clients were Not Followed-up (n = 260; 78%; Followed-up: n = 71; 22%). The analytical themes emerging from the decision notes suggested contextual factors-the clients' environment, their clinical relationships, and medical needs-mediated how clinicians interacted with the CDSS flags. Significant differences were found between medication subtypes and follow-up, with Anti-depressants less likely to be followed up than Anti-Psychotics and Anxiolytics (χ = 35.196, 44.825; p < 0.001; v = 0.389, 0.499); and between the time taken to action Followed-up and Not-followed up flags (M = 31.78; M = 45.55; U = 12,119; p < 0.001; η = .05).
These analyses encourage actively incorporating the input of consumers and carers, non-EHR data streams, and better incorporation of data from parallel health systems and other clinicians into CDSS designs to encourage follow-up.
对于患有精神健康问题的人来说,保持药物依从性可能具有挑战性。基于电子健康记录(EHR)中问题模式的自动检测的临床决策支持系统(CDSS)有可能通过建议基于证据的行动方案,从而对非依从性事件(“标记”)进行早期干预。然而,现有文献表明,在实际环境中,临床医生存在多种障碍,例如认为跟进低风险病例没有好处、数据真实性、以人为中心的设计问题等,从而导致他们无法跟进。本研究考察了与社区心理健康诊所中药物依从性提示相关的临床医生决策行为模式。
通过 CDSS 软件(AI)启用提示的跟进,并记录临床医生的回应。在审查提示后记录的去识别临床医生的注释使用主题合成方法进行分析-首先描述临床医生的评论,然后将其分类为与设计相关的分析主题,同时平行地使用描述性跟进行为的先验类别。根据文献中关于跟进类别与患者和药物亚型特征关系的假设进行了测试。
大多数患者未得到跟进(n=260;78%),得到跟进的患者(n=71;22%)。从决策说明中得出的分析主题表明,环境、临床关系和医疗需求等环境因素会影响临床医生与 CDSS 标记的交互方式。还发现药物亚型和跟进之间存在显著差异,与抗精神病药和抗焦虑药相比,抗抑郁药更不可能得到跟进(χ²=35.196,44.825;p<0.001;v=0.389,0.499);以及采取行动跟进和不跟进标记之间的时间差异(M=31.78;M=45.55;U=12119;p<0.001;η=0.05)。
这些分析鼓励积极纳入消费者和照顾者的投入、非 EHR 数据流以及更好地将来自并行健康系统和其他临床医生的数据纳入 CDSS 设计中,以鼓励跟进。